Session: Moderated Oral ePoster Session 06 - Bladder Cancer - Clinical and Bladder Cancer - Basic Science
MP-04.12: Preliminary Results From Legend: a Phase 2 Study of Detalimogene Voraplasmid, a Novel, Investigational, Non-Viral Genetic Medicine for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC)